Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer's disease in Mexican families.

Neurogenetics
Petra YescasMaría Elisa Alonso

Abstract

The etiology of Alzheimer's disease (AD) is complex. To date, molecular genetic studies in several families affected with AD have identified three genes associated with highly penetrant early-onset AD: Presenilin 1 (PSEN1), Presenilin 2 (PSEN2) and beta-amyloid precursor protein (APP); and one gene (apolipoprotein E) associated with late-onset AD. Molecular analysis of the PSEN1 gene was performed by direct sequencing of genomic DNA. The possible founder effect was investigated analyzing two highly polymorphic microsatellite markers flanking the PSEN1 gene. Twelve unrelated Mexican families with early-onset AD were analyzed. The Ala431Glu mutation in exon 12 of PSEN1 was found in nine (75%) of these families, which segregated showing autosomal dominant inheritance. Because all families bearing the mutation are from the State of Jalisco (located in Western Mexico), a founder effect was hypothesized. Microsatellite haplotype analysis suggested a common ancestor in these nine kindreds. In conclusion, the Ala431Glu mutation is a prevalent cause of early-onset familial Alzheimer's disease in families from the State of Jalisco, Mexico. Genetic evidence supports that it is a founder mutation descending from a single common ancestor. T...Continue Reading

References

Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Mar 31, 1998·Archives of Neurology·D Blacker, R E Tanzi
May 8, 1998·Molecular Medicine Today·W J RayA M Goate
Nov 17, 2001·JAMA : the Journal of the American Medical Association·E S AthanR Mayeux
Mar 14, 2002·American Journal of Human Biology : the Official Journal of the Human Biology Council·Ricardo M Cerda-FloresRanajit Chakraborty

❮ Previous
Next ❯

Citations

Jan 5, 2010·Journal of Neurology·John Matthew RingmanNoriko Salamon
Sep 29, 2011·Dementia and Geriatric Cognitive Disorders·Liana G ApostolovaJohn M Ringman
May 16, 2012·Dementia and Geriatric Cognitive Disorders·John M RingmanGal Bitan
Jan 1, 2014·Neurogenetics·Lizbeth E García-VelázquezPetra Yescas-Gómez
Feb 19, 2016·Journal of Neuropathology and Experimental Neurology·John M RingmanHarry V Vinters
Nov 13, 2012·Archives of Medical Research·María Elisa Alonso VilatelaPetra Yescas-Gómez
Oct 25, 2016·Neurobiology of Aging·Steffan K SoosmanJohn M Ringman
Sep 26, 2020·Dementia & Neuropsychologia·Claudia RamosFrancisco Lopera
Dec 31, 2019·Journal of Alzheimer's Disease : JAD·Rosalía A Santos-MandujanoMarco Antonio Meraz-Ríos
May 21, 2017·Journal of Alzheimer's Disease : JAD·Irving E VegaScott E Counts
Jul 27, 2018·Alzheimer's Research & Therapy·Celeste M KarchAlison M Goate
Oct 3, 2020·Case Reports in Neurological Medicine·Aljoharah AlakkasJonathan Bui
Nov 24, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Jorge J Llibre-GuerraRandall J Bateman
Dec 5, 2020·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Sofia Dumois-PetersenLuis E Figuera
Dec 15, 2020·Brain and Cognition·Luis D MedinaJohn M Ringman
Mar 18, 2021·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Maxwell B SingerAmir H Kashani
Mar 14, 2021·Journal of the American Geriatrics Society·Mellissa WithersFreddi Segal-Gidan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.